We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FARO
1626
DELISTED
Faro Technologies
FARO
$3.2M ﹤0.01%
48,620
-6,577
-12% -$463K
RDNT icon
1627
RadNet
RDNT
$5.69B
$3.2M ﹤0.01%
109,179
-16,041
-13% -$515K
BKE icon
1628
Buckle
BKE
$2.37B
$3.2M ﹤0.01%
80,775
-10,209
-11% -$436K
PFBC icon
1629
Preferred Bank
PFBC
$1.25B
$3.19M ﹤0.01%
47,894
+3,659
+8% +$224K
MATW icon
1630
Matthews International
MATW
$739M
$3.19M ﹤0.01%
91,865
-11,975
-12% -$411K
PRTA icon
1631
Prothena Corp
PRTA
$450M
$3.16M ﹤0.01%
44,414
+1,975
+5% +$123K
MDLA
1632
DELISTED
Medallia, Inc.
MDLA
$3.16M ﹤0.01%
93,278
-2,148
-2% -$71.7K
AMWD
1633
DELISTED
American Woodmark
AMWD
$3.15M ﹤0.01%
48,140
-7,030
-13% -$516K
HA
1634
DELISTED
Hawaiian Holdings, Inc.
HA
$3.15M ﹤0.01%
145,300
-19,207
-12% -$393K
TMP icon
1635
Tompkins Financial
TMP
$1.42B
$3.14M ﹤0.01%
38,848
-4,763
-11% -$370K
ENTA icon
1636
Enanta Pharmaceuticals
ENTA
$400M
$3.13M ﹤0.01%
55,160
-6,796
-11% -$336K
PBI icon
1637
Pitney Bowes
PBI
$2.39B
$3.13M ﹤0.01%
434,521
-76,457
-15% -$599K
INOV
1638
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$3.13M ﹤0.01%
77,768
-1,519
-2% -$57.4K
CSTM icon
1639
Constellium
CSTM
$3.99B
$3.13M ﹤0.01%
166,592
+5,200
+3% +$100K
DIN icon
1640
Dine Brands
DIN
$452M
$3.12M ﹤0.01%
38,450
-6,491
-14% -$522K
MGRC icon
1641
McGrath RentCorp
MGRC
$2.92B
$3.12M ﹤0.01%
43,362
+2,870
+7% +$211K
CARG icon
1642
CarGurus
CARG
$3.47B
$3.11M ﹤0.01%
99,043
+3,384
+4% +$98.7K
FUBO icon
1643
FuboTV Inc
FUBO
$273M
$3.1M ﹤0.01%
10,791
+302
+3% +$98.9K
CXW icon
1644
CoreCivic
CXW
$3.19B
$3.1M ﹤0.01%
348,446
-45,338
-12% -$442K
INVA icon
1645
Innoviva
INVA
$1.48B
$3.09M ﹤0.01%
185,131
-42,276
-19% -$632K
DMC
1646
Del Monte Corp
DMC
$1.45B
$3.09M ﹤0.01%
95,890
-6,797
-7% -$214K
JYNT icon
1647
The Joint Corp
JYNT
$119M
$3.09M ﹤0.01%
31,519
-3,503
-10% -$328K
SAFE
1648
DELISTED
Safehold Inc.
SAFE
$3.08M ﹤0.01%
42,917
-6,325
-13% -$536K
TOWN icon
1649
Towne Bank
TOWN
$3.42B
$3.08M ﹤0.01%
99,093
+2,463
+3% +$74.1K
BOKF icon
1650
BOK Financial
BOKF
$8.74B
$3.06M ﹤0.01%
34,189
-2,364
-6% -$202K

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.